x

Enroll Your Compounds in One of Our Tumor Organoid Screening Packages Today

Tumor organoids are superior 3D in vitro models with enhanced predictivity for more clinically relevant early drug development.
Tumor organoid screens provide more translatable in vitro data to improve success rates of your new anticancer agents.

You can now achieve rapid results through our preset tumor organoid screening packages, with organoids developed using exclusive HUB protocols.


Select the Right Tumor Organoid
Screening Package For Your Program

Efficacy Quantification

Compare efficacy
quantitatively

Why Choose our Efficacy Quantification Screen?

To quantitatively evaluate the efficacy and potency of your agent/s across models representing a heterogenous patient population

  • Quantify efficacy across patients and compounds and predict in vivo response
  • Standard IC50 design (9 concentrations)
  • Standard triplicates, CTG readout



Request More Info

Combination Strategy

Optimize
combination regimens

Why Choose our Combination Strategy Screen?

To identify optimal dosing for your combination strategies

  • Evaluate multiple strategies and find optimal in vivo dosing combination
  • Standard combination matrix options:
    • 6x6: CTG readout, standard triplicates
    • 1x9: Test agent A fixed concentration + test agent B IC50
    • 1:1 fixed ratio IC50: 2 test agents fixed ratio, diluted together in standard IC50 format



Request More Info

Library Screening

Identify your
lead compound

Why Choose our Library Screen?

To rapidly identify your lead agent from a library of 10+ compounds

  • Improve the patient-relevance of your hit-finding with our extensive organoid library
  • Single or multiple concentrations
  • Standard triplicates for each concentration, CTG readout
  • Minimum of 10 compounds/model required



Request More Info

Efficacy Quantification

Compare efficacy
quantitatively

Why Choose our Efficacy Quantification Screen?

To quantitatively evaluate the efficacy and potency of your agent/s across models representing a heterogenous patient population

  • Quantify efficacy across patients and compounds and predict in vivo response
  • Standard IC50 design (9 concentrations)
  • Standard triplicates, CTG readout



Request More Info

Combination Strategy

Optimize
combination regimens

Why Choose our Combination Strategy Screen?

To identify optimal dosing for your combination strategies

  • Evaluate multiple strategies and find optimal in vivo dosing combination
  • Standard combination matrix options:
    • 6x6: CTG readout, standard triplicates
    • 1x9: Test agent A fixed concentration + test agent B IC50
    • 1:1 fixed ratio IC50: 2 test agents fixed ratio, diluted together in standard IC50 format



Request More Info

Library Screening

Identify your
lead compound

Why Choose our Library Screen?

To rapidly identify your lead agent from a library of 10+ compounds

  • Improve the patient-relevance of your hit-finding with our extensive organoid library
  • Single or multiple concentrations
  • Standard triplicates for each concentration, CTG readout
  • Minimum of 10 compounds/model required



Request More Info